<<< Projects Personnel Publications Investigator Bio

Publications

Selected Publications

1. Surendran K, Schiavi S, Hruska KA:: Wnt-dependent B-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis J Am Soc Nephrol 2005;16: 2373-2384

2. Hruska KA, Mathew S, Lund R, Qiu P and Pratt R: Hyperphosphatemia of chronic kidney disease Kid Int 2008 doi; 10.1038/ki2008.130

3. Mathew S, Lund R, Strebeck F, Tustison K,. Geurs T, Hruska K:: Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Neph 2007;18:122-130.

4. Sugatani T, Hruska KA:: Akt1/Akt2 and mammalian target of Rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors J Biol Chem 2005; 280:3583-3589

5. Mathew S, Tustison K, Sugatani T, Chaudhary LR, Rifas L, Hruska KA:: The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD J Am Soc Neph 2008;19: 1092-1105

6. Mathew S, Lund R, Chaudhary L, Geurs T, Hruska KA: Vitamin D Receptor Activators Can Protect against Vascular Calcification J Am Soc Neph 2008 doi.1681/ASN.2007080902

7. De Petris L, Hruska K, Chiechio S, Liapis H. : Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrology Dialysis Transplantation 2007;in press.

Selected Reviews

1. Hruska KA, Mathew S: The CKD-MBD Primer of Metabolic Bone Diseases and Disorders of Mineral Metabolism 2008 in press

2. Hendy GN, Hruska KA, Mathew S, Goltzman D:: New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int 2006;69:218-223

3. Mathew S, Davies M, Lund R, Saab G, Hruska KA:: The function and effect of bone morphogenetic protein-7 in kidney-bone and the bone-vascular links in chronic kidney disease. Euro J Clin Invest 2006;36:43-50.